- Conditions: Atrial Fibrillation; Electrical Cardioversion
Interventions: Drug: Magnesium Sulfate; Other: Placebo
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified May 2012 - Condition: Depression
Intervention: Dietary Supplement: Magnesium sulfate
Sponsors: University of Miami; University of Miami; Life Extension Foundation
Recruiting - verified May 2012 - Conditions: Pain, Postoperative; Postoperative Nausea and Vomiting
Interventions: Drug: Tumescent solution with dilute lidocaine and epinephrine; Drug: Tumescent Solution with dilute epinephrine
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Not yet recruiting - verified May 2012 - Condition: Atrial Fibrillation Ablation
Intervention: Drug: Adenosine arm
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin
Not yet recruiting - verified May 2012 - Condition: Ventricular Tachycardia
Interventions: Drug: amiodarone; Drug: sotalol; Device: Biosense Webster's NAVI-STAR Thermo-Cool
Sponsors: Duke University; Duke University; Duke Clinical Research Institute
Not yet recruiting - verified April 2012 - Condition: Pain on Propofol IV Injection
Interventions: Device: lidocaine/tetracaine transdermal patch (NDC 43469-864-01); Drug: Gebauer's Ethyl Chloride
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; ZARS Pharma Inc.
Recruiting - verified April 2012 - Condition: Pain
Intervention: Drug: 3% mepivacaine/2% lidocaine with 1:100,000 epinephrine combo
Sponsors: Ohio State University; Ohio State University
Not yet recruiting - verified April 2012 - Conditions: Ventricular Tachycardia; Ischemic
Interventions: Drug: Drug Treatment; Device: Catheter Ablation
Sponsors: Biosense Webster, Inc.; Biosense Webster, Inc.
Not yet recruiting - verified March 2012 - Condition: Healthy Volunteers
Interventions: Drug: Digoxin; Drug: Vandetanib
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: Chronic Stable Angina; Coronary Artery Disease; Atrial Fibrillation; Ventricular Tachycardia
Interventions: Drug: ranolazine; Drug: placebo
Sponsors: Cardiovascular Consultants of Nevada; Cardiovascular Consultants of Nevada; Gilead Sciences
Recruiting - verified March 2012 - Condition: Cardiac Surgery
Interventions: Drug: Amiodarone; Procedure: Cardioversion
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Conditions: Prehypertension; Hypertension
Interventions: Drug: Nebivolol; Drug: Metoprolol; Drug: Placebo
Sponsors: University of Colorado, Boulder; University of Colorado, Boulder; Forest Laboratories
Recruiting - verified May 2012 - Condition: Post-traumatic Stress Disorder
Interventions: Drug: Propranolol Hydrochloride; Other: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; Department of Defense; Northern California Institute of Research and Education
Not yet recruiting - verified May 2012 - Condition: Healthy Volunteers
Intervention: Drug: Lidocaine 7% + Tetracaine 7% cream
Sponsors: Galderma; Galderma
Recruiting - verified May 2012 - Condition: Shoulder Pain
Interventions: Drug: Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch; Drug: Triamcinolone Acetonide
Sponsors: Injury Care Medical Center; Injury Care Medical Center; Nuvo Research Inc.
Recruiting - verified March 2012 - Conditions: Abortion, Induced; Pain Management
Interventions: Drug: Lidocaine; Drug: Normal Saline
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Recruiting - verified March 2012 - Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Condition: Pain
Interventions: Drug: Lidocaine; Drug: Placebo
Sponsors: University of Pittsburgh; University of Pittsburgh; Society of Family Planning
Not yet recruiting - verified February 2012 - Conditions: Sturge Weber Syndrome; Port Wine Mark
Interventions: Drug: Timolol; Drug: Balanced salt ophthalmic solution
Sponsors: Wills Eye; Wills Eye; University of Medicine and Dentistry New Jersey
Not yet recruiting - verified February 2012 - Condition: Drug Induced Constipation
Interventions: Drug: Nektar 118; Drug: Quinidine; Drug: Quinidine placebo; Drug: Morphine
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: Atrial Fibrillation; Medication Adherence
Intervention: Other: Education and telephone follow-up
Sponsors: Creighton University; Creighton University; Sanofi-Aventis
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Magnesium Sulfate; Drug: Placebo
Sponsors: University of Louisville; University of Louisville
Recruiting - verified January 2012 - Condition: Glaucoma
Intervention: Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: PF-04937319 10 mg; Drug: PF-04937319 50 mg; Drug: PF-04937319 100 mg; Drug: Glimepiride
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Malignant Neoplasm
Interventions: Drug: placebo administration; Drug: EMLA; Drug: propofol; Drug: fentanyl citrate
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Atrial Fibrillation
Interventions: Drug: Placebo; Drug: Ranolazine; Drug: Dronedarone; Drug: Ranolazine and Dronedarone low dose 1; Drug: Ranolazine and Dronedarone low dose 2
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Glaucoma
Intervention: Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified March 2012 - Condition: Glaucoma
Intervention: Drug: Travoprost/Timolol Maleate BAK-Free Fixed Combination
Sponsors: Alcon Research; Alcon Research
Recruiting - verified April 2012 - Condition: Hypertension
Interventions: Drug: Nebivolol; Drug: atenolol; Drug: placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Forest Laboratories
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Conditions: Open-angle Glaucoma; Ocular Hypertension
Intervention: Drug: Travoprost/timolol fixed combination (Travacom)
Sponsors: Alcon Research; Alcon Research
Not yet recruiting - verified April 2012 - Condition: Onset and Duration of a Digital Nerve Block With 2 Local Anesthesthetics.
Interventions: Drug: Lidocaine; Drug: Bupivacaine
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified February 2012 - Condition: Atrial Fibrillation
Interventions: Drug: Antiarrhythmic drug; Procedure: Catheter ablation
Sponsors: Valley Health System; Valley Health System; Biosense Webster, Inc.
Recruiting - verified December 2011 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Conditions: Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer
Interventions: Drug: Propranolol; Drug: Chemotherapy; Procedure: Surgery; Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Acute Stroke
Intervention: Drug: Magnesium Sulfate
Sponsors: University of Southern California; University of Southern California; University of California, Los Angeles
Not yet recruiting - verified December 2011 - Conditions: Vulvodynia; Dyspareunia; Breast Cancer; Menopause
Intervention: Drug: Topical liquid lidocaine
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified February 2012 - Condition: Pharmacokinetics
Intervention: Drug: TAK-875 and Glimepiride
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Supraventricular Tachycardia
Interventions: Drug: Dexmedetomidine; Drug: Adenosine
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified February 2012 - Condition: Glaucoma
Intervention: Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified December 2011 - Condition: Hypertension
Interventions: Drug: Metoprolol succinate; Drug: Nebivolol; Drug: Hydrochlorothiazide; Drug: DEFINITY®; Procedure: Non-invasive measurement of Cardiac Output (CO); Procedure: Flow mediated vasodilation; Procedure: Endothelial cell collection; Procedure: Microvascular perfusion assessment using Definity
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; Forest Laboratories
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: TAK-875; Drug: TAK-875; Drug: Glimepiride
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Arrhythmia
Interventions: Drug: Amiodarone Plus Ranolazine; Drug: Amiodarone with Placebo
Sponsors: Hartford Hospital; Hartford Hospital; Gilead Sciences
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Atorvastatin; Other: Placebo to sitagliptin; Other: Placebo to atorvastatin; Drug: Metformin; Drug: Glimepiride; Drug: Placebo to glimepiride
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Nephropathy; Sickle Cell Anemia
Intervention: Drug: Losartan
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Drug: FFR Measurement with IV Adenoscan® then with Regadenoson
Sponsors: Ochsner Health System; Ochsner Health System; Astellas Pharma Global Development, Inc.
Recruiting - verified March 2012 - Condition: Interstitial Cystitis
Interventions: Drug: Lidocaine Releasing Intravesical System - LiRIS®; Other: LiRIS Placebo; Procedure: Sham
Sponsors: TARIS Biomedical, Inc.; TARIS Biomedical, Inc.
Recruiting - verified May 2012 - Conditions: Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Implantable Cardioverter Defibrillator
Interventions: Drug: Azimilide Dihydrochloride; Drug: Placebo
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified May 2012 - Condition: Pain
Intervention: Drug: Paracervical block technique with lidocaine
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Planned Parenthood Federation of America
Recruiting - verified February 2012 - Condition: Hypertension
Interventions: Drug: Metoprolol succinate; Drug: Nebivolol; Procedure: Forearm blood flow; Procedure: Microneurography; Procedure: Rhythmic handgrip exercise; Procedure: Lower body negative pressure; Drug: Angiotensin II
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; Forest Laboratories
Recruiting - verified April 2012 - Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684; Drug: Quinidine
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Conditions: Peripheral Artery Disease; Hypertension
Interventions: Drug: nebivolol; Drug: Metoprolol succinate
Sponsors: Thomas Jefferson University; Thomas Jefferson University; Forest Laboratories
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650; Drug: glimepiride
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650 60 mcg/day; Drug: glimepiride
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Conditions: Transplant; Failure, Kidney; Hypertension
Interventions: Drug: Nebivolol; Drug: Metoprolol succinate
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Forest Laboratories; Lahey Clinic
Recruiting - verified February 2012 - Condition: Neoplasms
Interventions: Drug: Gemcitabine; Drug: BAY80-6946; Drug: Cisplatin; Drug: NaCl; Drug: BAY80-6964 fixed dose
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Conditions: Pain; Opioid Use, Unspecified, Uncomplicated
Interventions: Drug: Placebo infusion of .9 normal saline; Drug: administration of magnesium sulfate
Sponsors: Northwestern University; Northwestern University
Recruiting - verified February 2012 - Conditions: Infantile Hemangioma; Very Low Birth Weight Infants; Prematurity
Interventions: Drug: topical 0.5% Timolol; Drug: Control (placebo) group
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio
Not yet recruiting - verified September 2011 - Condition: Glaucoma
Interventions: Drug: bimatoprost ophthalmic solution formulation A, bimatoprost vehicle; Drug: timolol ophthalmic solution
Sponsors: Allergan; Allergan
Recruiting - verified November 2011 - Condition: Primary Hypomagnesemia (Disorder)
Intervention: Drug: Magnesium Sulfate
Sponsors: CAMC Health System; CAMC Health System; Sara and Pauline Maier Foundation, Inc.
Recruiting - verified December 2011 - Condition: Pain
Interventions: Drug: Lidocaine; Drug: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Atrial Fibrillation
Interventions: Drug: Amiodarone; Drug: Minocycline
Sponsors: Baystate Medical Center; Baystate Medical Center
Recruiting - verified December 2011 - Conditions: Pain; Intrauterine Device
Interventions: Drug: 2% lidocaine gel; Drug: Water based lubricant
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Condition: PKU
Interventions: Dietary Supplement: diet; Drug: sapropterin dihydrochloride
Sponsors: Children's Research Institute; Children's Research Institute; Georgetown University
Recruiting - verified March 2012 - Condition: Uterine Cervical Dysplasia
Intervention: Drug: sodium bicarbonate buffered lidocaine
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Condition: Myotonic Dystrophy
Interventions: Drug: Mexiletine; Drug: Placebo
Sponsors: University of Rochester; University of Rochester; FDA Office of Orphan Products Development
Recruiting - verified July 2011 - Condition: Cardiac Arrest
Interventions: Drug: amiodarone; Drug: Lidocaine; Other: Normal saline
Sponsors: University of Washington; University of Washington; National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada; American Heart Association; Defence Research and Development Canada; U.S. Army Medical Research and Materiel Command
Not yet recruiting - verified February 2012 - Conditions: Complication of Injection; Pain
Interventions: Drug: Fospropofol; Drug: Propofol/Lidocaine
Sponsors: New York University School of Medicine; New York University School of Medicine; Eisai Inc.
Recruiting - verified November 2011 - Condition: Pain
Interventions: Drug: 2% lidocaine gel; Drug: 0.5% tetracaine drops
Sponsors: University of Miami; University of Miami
Recruiting - verified October 2010 - Conditions: Prehypertension; Hypertension
Interventions: Drug: Nebivolol; Drug: Metoprolol; Drug: Placebo
Sponsors: University of Colorado, Boulder; University of Colorado, Boulder; Forest Laboratories
Recruiting - verified May 2012 - Conditions: Pain; Anxiety
Interventions: Device: Buzzy; Drug: Topical Lidocaine 4% Cream
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified May 2012 - Conditions: Open-angle Glaucoma; Ocular Hypertension
Interventions: Drug: Brinzolamide 1% +Timolol 0.5% fixed combination; Drug: Brinzolamide 1% and Timolol 0.5%
Sponsors: Alcon Research; Alcon Research
Recruiting - verified November 2011 - Condition: Glaucoma
Interventions: Drug: Brinzolamide/Timolol Maleate Fixed Combination (Azarga); Drug: Dorzolamide/Timolol Maleate Fixed Combination (Cosopt)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified November 2011 - Condition: Glaucoma
Intervention: Drug: Travoprost/Timolol Maleate Fixed Combination
Sponsors: Alcon Research; Alcon Research
Recruiting - verified January 2012 - Condition: Traumatic Brain Injury
Interventions: Device: Arctic Sun; Drug: Magnesium Sulfate
Sponsors: Department of Defense; Department of Defense
Recruiting - verified December 2011 - Condition: Atrial Fibrillation
Intervention: Other: No Amiodarone
Sponsors: Inova Health Care Services; Inova Health Care Services
Recruiting - verified April 2012 - Condition: Glaucoma
Intervention: Drug: Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination ophthalmic solution (DUOTRAV)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified April 2012 - Condition: Infantile Hemangiomas
Interventions: Drug: Timolol 0.5% topical; Drug: Mupirocin
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia; Society for Pediatric Dermatology
Recruiting - verified August 2011 - Conditions: Brain Injuries; Craniocerebral Trauma; Trauma, Nervous System; Traumatic Brain Injury
Interventions: Drug: IV Propranolol and Per Tube Clonidine; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified March 2012 - Condition: Post-operative Pain
Interventions: Drug: Bupivacaine / Lidocaine; Drug: Lidocaine
Sponsors: Baylor Research Institute; Baylor Research Institute
Recruiting - verified February 2012 - Condition: Local Anesthetics
Interventions: Drug: Lidocaine; Drug: normal saline; Drug: alkalinized lidocaine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified December 2011 - Conditions: Invasive Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer
Intervention: Drug: Propranolol (Inderal)
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Conditions: Hypertension; Pure Autonomic Failure; Multiple System Atrophy
Interventions: Drug: Losartan; Drug: Captopril; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib; Drug: VT-122 (propranolol plus etodolac); Drug: Placebo
Sponsors: Vicus Therapeutics; Vicus Therapeutics
Recruiting - verified May 2012 - Condition: Glaucoma
Intervention: Drug: Brinzolamide/Timolol Maleate Fixed Combination (Azarga)
Sponsors: Alcon Research; Alcon Research
Recruiting - verified November 2011 - Condition: Benign Vascular Periocular Lesions
Intervention: Drug: topical Timolol
Sponsors: Loyola University; Loyola University
Recruiting - verified September 2011 - Condition: Pain
Interventions: Drug: Placebo; Drug: Group A (study group) Lidocaine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified October 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: glimepride placebo; Drug: linagliptin placebo; Drug: linagliptin; Drug: glimepiride
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Hypertension; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: lisinopril; Drug: losartan potassium; Other: laboratory biomarker analysis; Drug: benazepril hydrochloride; Drug: ramipril
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University
Recruiting - verified April 2012 - Condition: Atrial Fibrillation
Intervention: Drug: Procainamide
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified August 2011 - Condition: Traumatic Brain Injury
Intervention: Drug: Propranolol
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center
Recruiting - verified June 2010 - Condition: Contraception
Interventions: Drug: Lidocaine; Drug: Lubricant
Sponsors: University of Tennessee; University of Tennessee
Recruiting - verified June 2011 - Condition: Postural Tachycardia Syndrome
Interventions: Drug: Losartan; Drug: Ascorbic Acid (Vitamin C); Drug: Normal Saline
Sponsors: New York Medical College; New York Medical College
Recruiting - verified December 2011 - Conditions: Pain; Obesity
Interventions: Drug: Lidocaine Infusion; Drug: Normal Saline
Sponsors: Northwestern University; Northwestern University
Recruiting - verified May 2012 - Condition: Prostate Cancer
Intervention: Drug: Digoxin
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: adenosine; Drug: regadenoson; Drug: Adenosine
Sponsors: St. Louis University; St. Louis University; University of Florida; Astellas Pharma US, Inc.
Recruiting - verified July 2011 - Conditions: Pain Perception; Phlebotomy
Interventions: Drug: 4% lidocaine gel application with sham microneedle device; Drug: Microneedle-facilitated lidocaine application
Sponsors: University of Oklahoma; University of Oklahoma
Not yet recruiting - verified March 2012 - Condition: Phenylketonuria
Interventions: Drug: Sapropterin dihydrochloride; Drug: Placebo
Sponsors: BioMarin Pharmaceutical; BioMarin Pharmaceutical
Recruiting - verified November 2011 - Conditions: Chemotherapeutic Agent Toxicity; Colorectal Cancer; Neuropathy; Neurotoxicity
Interventions: Drug: calcium gluconate; Drug: magnesium sulfate; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Diabetic Peripheral Neuropathy
Interventions: Other: Skin biopsy; Other: Skin biopsy
Sponsors: Albany Medical College; Albany Medical College; Endo Pharmaceuticals
Recruiting - verified December 2010 - Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Children's Hospital Boston; Washington University School of Medicine; LaJolla Institute for Allergy and Immunology; National Heart, Lung, and Blood Institute (NHLBI); Astellas Pharma Global Development, Inc.
Recruiting - verified June 2011 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Alcohol Dependence; PTSD
Interventions: Drug: Propranolol; Drug: Placebo
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified November 2011 - Condition: Induced Abortion
Interventions: Drug: intra-fetal digoxin injection; Drug: intra-amniotic digoxin injection
Sponsors: White, Katharine O'Connell, M.D., M.P.H.; White, Katharine O'Connell, M.D., M.P.H.; Society of Family Planning
Recruiting - verified November 2011 - Conditions: Hypertension; Pure Autonomic Failure; Multiple System Atrophy
Interventions: Drug: Placebo; Drug: Nebivolol 5 mg; Drug: metoprolol tartrate 50 mg; Drug: Sildenafil25 mg
Sponsors: Vanderbilt University; Vanderbilt University; Forest Laboratories
Recruiting - verified May 2012 - Condition: Persistent Atrial Fibrillation
Interventions: Drug: Ibutilide; Drug: Placebo
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; St. Jude Medical
Recruiting - verified January 2012 - Conditions: Parkinson Disease; Huntington Disease
Intervention: Drug: [123I]MNI-420
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Hemangioma of Infancy
Interventions: Drug: propranolol; Drug: Prednisolone
Sponsors: Children's Research Institute; Children's Research Institute
Recruiting - verified October 2011 - Condition: Amblyopia
Interventions: Drug: Atropine; Device: Plano lens; Drug: Atropine
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Condition: Cognitive Decline
Interventions: Drug: Lidocaine; Drug: Placebo
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); CAS Medical Systems, Inc.
Recruiting - verified May 2012 - Conditions: Atrial Fibrillation; Arrhythmia; Stroke Prevention; Mortality
Interventions: Device: Left atrial ablation; Drug: Rate or Rhythm Control Therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); St. Jude Medical; Biosense Webster, Inc.
Recruiting - verified April 2012 - Conditions: Stroke; Cerebrovascular Accident
Interventions: Drug: lidocaine; Device: muscle stimulator
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified May 2010 - Condition: Healthy
Intervention: Drug: Atenolol (β-blocker)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: Adalimumab; Drug: Lisinopril, losartan, and atorvastatin; Drug: galactose
Sponsors: New York University School of Medicine; New York University School of Medicine; University of Michigan; The Cleveland Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 - Condition: Cardiomyopathy
Intervention: Drug: Metoprolol
Sponsors: University of Maryland; University of Maryland
Recruiting - verified October 2011 - Condition: Severe Combined Immunodeficiency
Intervention: Biological: ADA gene transfer
Sponsors: University of California, Los Angeles; University of California, Los Angeles; FDA Office of Orphan Products Development; National Institutes of Health (NIH)
Recruiting - verified June 2011 - Condition: Cystic Fibrosis
Interventions: Drug: digitoxin; Drug: digitoxin; Other: placebo
Sponsors: Johns Hopkins University; Pamela L. Zeitlin, MD, PhD; FDA Office of Orphan Products Development
Recruiting - verified May 2012 - Conditions: Pre-diabetes; Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Sitagliptin; Drug: Glimepiride
Sponsors: University of Pennsylvania; University of Pennsylvania; Pennsylvania Department of Health
Recruiting - verified November 2011 - Conditions: Orthostatic Intolerance; Postural Tachycardia Syndrome
Interventions: Drug: Propanolol; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Ischemia; Coronary Disease
Intervention:
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; Department of Defense
Recruiting - verified July 2011 - Condition: Myocardial Ischemia
Interventions: Drug: Metoprolol; Drug: Esmolol; Drug: Placebo
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified August 2011 - Condition: Hypertension
Intervention: Drug: losartan potassium
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Conditions: Leukemia; Chronic Lymphocytic Leukemia
Intervention: Drug: 8-Chloro-Adenosine
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI); FDA Office of Orphan Products Development
Recruiting - verified March 2012 - Condition: Cocaine Dependence
Interventions: Drug: Propranolol; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Shoulder Pain
Interventions: Drug: Lidocaine; Drug: Triamcinolone + Lidocaine; Drug: Triamcinolone + Lidocaine; Drug: Triamcinolone + Lidocaine
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2011 - Condition: Posttraumatic Stress Disorders
Interventions: Drug: Propranolol; Drug: Placebo
Sponsors: Yale University; Yale University; Department of Veterans Affairs; New York University
Recruiting - verified January 2012 - Condition: Ventricular Tachycardia
Interventions: Drug: clonidine; Drug: metoprolol
Sponsors: University of Iowa; University of Iowa; National Center for Research Resources (NCRR)
Recruiting - verified December 2007 - Condition: Burns
Interventions: Procedure: Stable Isotope Infusion Study; Procedure: Collection of blood and tissues; Procedure: Radiology testing: DEXA, K+ counter, ultrasound, MRI; Drug: Humatrope; Drug: Ketoconazole; Drug: Oxandrolone; Drug: Propranolol; Drug: Oxandrolone and propranolol combined; Drug: Humatrope and propranolol combined; Drug: Placebo; Behavioral: Exercise--Hospital supervised intensive exercise program; Behavioral: Home exercise program
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; U.S. Department of Education; National Institutes of Health (NIH); Shriners Hospitals for Children
Recruiting - verified March 2012 - Conditions: Atrial Fibrillation; Pulmonary Vein Ablation
Intervention: Drug: Ibutilide fumarate
Sponsors: Ball Memorial Hospital; Ball Memorial Hospital; St. Jude Medical
Recruiting - verified January 2012 - Conditions: Hemodialysis; Hypertension; Left Ventricular Hypertrophy
Interventions: Drug: Lisinopril; Drug: Atenolol
Sponsors: Indiana University; Indiana University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Kidney Disease; Nephropathy; Type 2 Diabetes
Interventions: Drug: losartan; Drug: lisinopril; Drug: losartan
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Hermansky-Pudlak Syndrome (HPS); Pulmonary Fibrosis; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Metabolic Disease
Interventions: Drug: Losartan; Drug: Zileuton; Drug: N-Acetylcysteine; Drug: Prevastatin; Drug: Erythromycin
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified December 2010 - Conditions: Tachycardia; Chronic Orthostatic Intolerance
Interventions: Drug: Acetazolamide; Drug: Atomoxetine; Other: Baseline (No Drug); Drug: Clonidine; Drug: Entacapone; Drug: Entacapone & Propranolol; Drug: Atomoxetine & Propranolol; Drug: Indomethacin; Drug: Mecamylamine; Drug: Isosorbide Dinitrate; Dietary Supplement: Melatonin; Drug: Midodrine; Drug: Modafinil; Drug: Octreotide; Radiation: Placebo; Drug: Propranolol; Drug: Modafinil & Propranolol; Drug: Sertraline; Procedure: IV Saline; Other: Drinking Water; Device: Breathing Device; Drug: memantine; Device: Abdominal binder
Sponsors: Vanderbilt University; Satish R. Raj; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Hypertension
Interventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other: Head-up tilt.
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Abruptio Placentae
Intervention: Drug: magnesium sulfate, Normal Saline
Sponsors: Stanford University; Stanford University
Recruiting - verified April 2012 - Condition: Cerebrovascular Accident
Interventions: Drug: Magnesium Sulfate; Drug: Normal Saline
Sponsors: University of California, Los Angeles; Jeffrey L. Saver; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified December 2011 - Condition: Severe Combined Immunodeficiency Syndrome
Intervention: Drug: CD34+ cells transduced with ADA retrovir
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified February 2012
 |
Anti Arrhythmia Agents Clinical Trials |
